Page 17 of articles about vaccine

Protection of European domestic pigs from virulent African isolates of African swine fever virus by experimental immunization

Experimental immunisation of pigs with the non-virulent OURT88/3 genotype I isolate from Portugal followed by the closely related virulent OURT88/1 genotype I isolate could confer protection against challenge with virulent isolates from Africa.

Home

Press releases

Inovio Pharmaceuticals enters collaboration with U.S. Dept. of Homeland Security to assess foot & mouth disease synthetic vaccines' potential to help ensure Nation's food supply safety

Inovio Pharmaceuticals, Inc., a leader in the development of synthetic immunogens against cancers and infectious diseases, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Department of Homeland Security (DHS) Science and Technology Directorate Plum Island Animal Disease Center. This collaboration will evaluate the efficacy of Inovio's SynCon® vaccines for foot & mouth disease (FMD) in important animal models including cattle, sheep, and pigs.

Home

Abstract

Effect of vaccination of pigs against experimental infection with high and low virulence Mycoplasma hyopneumoniae strains

This study investigated the infection pattern and lung lesion development in pigs caused by a low and highly virulent Mycoplasma hyopneumoniae strain.

Home

Press releases

RespiSure-ONE^® now registered for use in day old piglets

Canadian swine producers can now vaccinate for mycoplasma pneumonia when they process baby pigs. A new label claim makes RespiSure-ONE the only vaccine approved for administration at one day of age.

Home

Press releases

Pfizer Animal Health launches Fostera^TM PCV a new porcine circovirus vaccine

Nearly every pig in Canada receives a vaccine for protection against porcine circovirus (PCV), and now swine producers have a new option for efficacious protection with the registration of Fostera PCV from Pfizer Animal Health.

Home

Abstract

Transmission patterns of influenza virus in vaccinated and non-vaccinated pig populations

The objective of this study was to determine Ro of flu in non-immune populations and in populations of pigs vaccinated with homologous or heterologous vaccines and to assess how vaccination may affect transmission.

Home

Press releases

Merck Animal Health expands vaccine manufacturing unit at Elkhorn Biotechnology Excellence Center

Merck Animal Health (MSD Animal Health outside the USA and Canada), formerly known as Intervet/Schering-Plough Animal Health, has opened today an expansion of a vaccine manufacturing unit at its Elkhorn Biotechnology Excellence Center.

Home

Abstract

Circovirus vaccination in pigs with subclinical porcine circovirus type 2 infection complicated by ileitis

This study demonstrated a clear benefit in vaccinating pigs subclinically infected with porcine circovirus type 2 (PCV2) with a one-dose PCV2 vaccine.

Home

Press releases

SDSU, Boehringer Ingelheim team up against enterotoxic E. coli

South Dakota State University is partnering with animal health leader Boehringer Ingelheim Vetmedica, Inc. to develop a new technology to protect pigs against a deadly form of E. coli.

Home

Article

Eradication of FMD in the Philippines (II)

In 1996, the NFMDTF drafted a national plan to address the 1995 FMD epidemic wherein 98,000 animals were reported to have been affected.

Home

Press releases

Merck Animal Health breaks ground for $18 million vaccine plant expansion

Merck Animal Health, formerly known as Intervet/Schering-Plough Animal Health, announced today that it has embarked on the expansion of a vaccine manufacturing unit at its Biosciences Center Boxmeer campus in the Netherlands.

Home

Article

Eradication of FMD in the Philippines (I)

The FMD Eradication Project in the Philippines has formally ended but activities have been sustained even after obtaining FMD-freedom in Luzon having no clinical cases for 5 years with the last outbreak recorded in December 28, 2005.

Home

Press releases

Bioniche chief veterinary scientific officer discusses vaccine against E. coli O157 at International meat industry conference

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that its Chief Veterinary Scientific Officer, Dr. Dragan Rogan, was an invited speaker at the 56th International Meat Industry Conference being held in Tara, Serbia.

Home

News

Vietnam boosts animal vaccine reserve

Vietnam’s prime minister has allocated an additional VND 70.6 billion (USD3.36 million) for the Ministry of Agriculture and Rural Development to buy animal-disease vaccine and disinfection chemicals for national reserve in 2011.

Home

Press releases

Improved vaccine against progressive atrophic rhinitis in swine launched by Intervet/Schering-Plough Animal Health

Intervet/Schering-Plough Animal Health announces today that it is introducing PORCILIS® AR-T DF, an inactivated vaccine against progressive atrophic rhinitis in piglets with a new adjuvant associated with fewer injection site reactions.

Home

Press releases

Animal Health and Food Safety vaccine manufacturing centre officially opens in Belleville, Ontario, Canada

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today officially opened its new Animal Health and Food Safety Vaccine Manufacturing Centre at its corporate headquarters in Belleville, Ontario, Canada.